Literature DB >> 35655351

In reply.

David Hardung.   

Abstract

Entities:  

Year:  2022        PMID： 35655351      PMCID： PMC9229583          DOI： 10.3238/arztebl.m2022.0049

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   8.251


× No keyword cloud information.
  4 in total

1.  Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both.

Authors:  Keith A A Fox; Sonia S Anand; Victor Aboyans; Martin R Cowie; E Sebastian Debus; Uwe Zeymer; Danja Monje; Kai Vogtländer; Robert Lawatscheck; Alain Gay
Journal:  Am Heart J       Date:  2020-01-28       Impact factor: 4.749

Review 2.  Antithrombotic Treatment for Peripheral Arterial Occlusive Disease.

Authors:  David Hardung; Andrea Behne; Mehmet Boral; Carsten Giesche; Ralf Langhoff
Journal:  Dtsch Arztebl Int       Date:  2021-08-09       Impact factor: 8.251

Review 3.  Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis.

Authors:  Konstantinos Katsanos; Stavros Spiliopoulos; Prakash Saha; Athanasios Diamantopoulos; Narayan Karunanithy; Miltiadis Krokidis; Bijan Modarai; Dimitris Karnabatidis
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

4.  Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy.

Authors:  Victor Aboyans; Rupert Bauersachs; Lucia Mazzolai; Marianne Brodmann; José F Rodriguez Palomares; Sebastian Debus; Jean-Philippe Collet; Heinz Drexel; Christine Espinola-Klein; Basil S Lewis; Marco Roffi; Dirk Sibbing; Henrik Sillesen; Eugenio Stabile; Oliver Schlager; Marco De Carlo
Journal:  Eur Heart J       Date:  2021-10-14       Impact factor: 35.855
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.